ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,688 Cr | ₹1,554 Cr | ₹1,225 Cr | ₹1,111 Cr | ₹1,237 Cr |
What is the latest Total Liabilities ratio of ORCHID PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,688 Cr |
| Mar2024 | ₹1,554 Cr |
| Mar2023 | ₹1,225 Cr |
| Mar2022 | ₹1,111 Cr |
| Mar2021 | ₹1,237 Cr |
How is Total Liabilities of ORCHID PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,688 Cr | 8.62 | |
| Mar2024 | ₹1,554 Cr | 26.83 | |
| Mar2023 | ₹1,225 Cr | 10.32 | |
| Mar2022 | ₹1,111 Cr | -10.24 | |
| Mar2021 | ₹1,237 Cr | - | |
Compare Total Liabilities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹2,719.5 Cr | 6.3% | -19.8% | -35.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 6.3% |
-19.8% |
-35.9% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses